Envision Healthcare (EVHC) Reports Q1 EPS of $0.77, FY Guidance Falls Short
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- S&P 500, Nasdaq futures rise on tech boost
- Why this Wall Street strategist says the "trade is long gold"
- U.S. EV market shows signs of bottoming out: Bernstein
- Oil rises on Iran war stalemate; near-term potential for further gains seen limited
- L3Harris CEO steps down amid conduct review, shares drop
- S&P 500 ends lower as investors weigh data, Middle East tensions
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
- BOJ eyeing September rate hike, faster pace of tightening, sources say
Envision Healthcare Reports 2017 First Quarter Financial Results
May 2, 2017 4:05 PM EDT2017 Financial Outlook Updated
NASHVILLE, Tenn. & GREENWOOD VILLAGE, Colo.--(BUSINESS WIRE)-- Envision Healthcare Corporation (Envision) (NYSE: EVHC) today reported financial results for the three months ended March 31, 2017. These results reflect the reporting of Envisions Medical Transportation segment as discontinued operations for the period, after the Board of Directors approved a plan to market that business, and eventually divest it, to prospective buyers.
Highlights for the First Quarter of 2017 include:
Net revenue of $1.88 billion from continuing operations and $593.5 million from discontinued operations;... More
